{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:16:10Z","timestamp":1791299770902,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s11239-011-0550-4","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T06:25:46Z","timestamp":1294899946000},"page":"82-88","source":"Crossref","is-referenced-by-count":73,"title":["Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties"],"prefix":"10.1007","volume":"32","author":[{"given":"Federico","family":"Cacciapuoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"550_CR1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.274.13.1049","volume":"74","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probables benefits of increasing folic acid intakes. J Am Med Assoc 74:1049\u20131057","journal-title":"J Am Med Assoc"},{"key":"550_CR2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM200202143460702","volume":"346","author":"J Loscalzo","year":"2002","unstructured":"Loscalzo J (2002) Homocysteine and dementias. N Engl J Med 346:466\u2013468","journal-title":"N Engl J Med"},{"key":"550_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshardi","year":"2002","unstructured":"Seshardi S, Beiser A, Selhub J, Jacques PF, Rosenberg IHG et al (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med 346:476\u2013483","journal-title":"N Engl J Med"},{"key":"550_CR4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1515\/CCLM.2007.362","volume":"45","author":"W Herrmann","year":"2007","unstructured":"Herrmann W, Herrmann M, Joseph J, Tyagi SC (2007) The role of hyperhomocysteinemia as well as folate. Vitamin B (6) and B (12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 45:1621\u20131632","journal-title":"Clin Chem Lab Med"},{"key":"550_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0009-8981(02)00287-5","volume":"326","author":"MT Agullo-Ortuno","year":"2002","unstructured":"Agullo-Ortuno MT, Albaladejo MD, Parra S, Rodriguez-Manotas M, Fenollar M et al (2002) Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Clin Chem Acta 326:105\u2013112","journal-title":"Clin Chem Acta"},{"key":"550_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","volume":"338","author":"MRC Vitamin Study Research Group","year":"1991","unstructured":"MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338:131\u2013137","journal-title":"Lancet"},{"key":"550_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","volume":"19","author":"J Selhub","year":"1999","unstructured":"Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217\u2013246","journal-title":"Annu Rev Nutr"},{"key":"550_CR8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1053\/euhj.2002.3172","volume":"23","author":"P O\u2019Callaghan","year":"2002","unstructured":"O\u2019Callaghan P, Meleady R, Fitzerald T et al (2002) Smoking and plasma homocysteine. Eur Heart J 23:1580\u20131586","journal-title":"Eur Heart J"},{"key":"550_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10623320701421487","volume":"14","author":"A Erol","year":"2007","unstructured":"Erol A, Cinar MG, Can C, Olukuman M, Ulker S, Kosay S (2007) Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells. Endothelium 14:157\u2013161","journal-title":"Endothelium"},{"key":"550_CR10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jcb.20578","volume":"96","author":"N Tyagi","year":"2005","unstructured":"Tyagi N, Moshal KS, Ovechkin AV, Rodriguez W, Steed M, Henderson B, Roberts AM, Joshua IG, Tyagi SC (2005) Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. J Cell Biochem 96:665\u2013671","journal-title":"J Cell Biochem"},{"key":"550_CR11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.1175","volume":"82","author":"VS Mujumdar","year":"2001","unstructured":"Mujumdar VS, Aru GM, Tyagi SC (2001) Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 82:491\u2013500","journal-title":"J Cell Biochem"},{"issue":"1","key":"550_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","volume":"90","author":"A D\u2019Angelo","year":"1997","unstructured":"D\u2019Angelo A, Selhub J (1997) Homocysteine and thrombotic disease. Blood 90(1):1\u201311","journal-title":"Blood"},{"key":"550_CR13","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042\u20131050","journal-title":"N Engl J Med"},{"key":"550_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M Heijer den","year":"1996","unstructured":"den Heijer M, Kostor T, Blom HJ, Bos GM, Briest E, Reitsma PH et al (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759\u2013762","journal-title":"N Engl J Med"},{"key":"550_CR15","unstructured":"Schesselman LS (2003) Novel factor for atherosclerotic disease. Retrieved 29 December 2003, from http\/\/.medscape.com\/viewarticle\/418378"},{"key":"550_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.12.007","volume":"17","author":"A Towfighi","year":"2008","unstructured":"Towfighi A, Saver JL, Engelhardt R, Ovbiagele B (2008) Factors associated with the steep increase in late mild life stroke occurrence among US men. J Stroke Cerebrovasc Dis 17:165\u2013168","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"550_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.9.121","volume":"9","author":"R Kawamoto","year":"2002","unstructured":"Kawamoto R, Kajiwara T, Oka Y, Takagi Y (2002) An association between plasma homocysteine concentrations and ischemic stroke in elderly Japanese. J Atheroscler Thromb 9:121\u2013125","journal-title":"J Atheroscler Thromb"},{"key":"550_CR18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230\u2013236","journal-title":"N Engl J Med"},{"key":"550_CR19","first-page":"111","volume":"56","author":"KS Mc Cully","year":"1969","unstructured":"Mc Cully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol 56:111\u2013128","journal-title":"Am J Pathol"},{"key":"550_CR20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh023","volume":"127","author":"A Hassan","year":"2004","unstructured":"Hassan A, Hunt BJ, O\u2019Sullivan M, Bell R, D\u2019Souza R, Jeffery S, Bamford JM, Markus HS (2004) Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127:212\u2013219","journal-title":"Brain"},{"key":"550_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.5551\/jat.4796","volume":"17","author":"SK Jeong","year":"2010","unstructured":"Jeong SK, Seo JY, Cho YI (2010) Homocysteine and internal carotid artery occlusion in ischemic stroke. J Ather Thromb 17:963\u2013969","journal-title":"J Ather Thromb"},{"key":"550_CR22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 288:2015\u20132022","journal-title":"J Am Med Assoc"},{"key":"550_CR23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","volume":"298","author":"RJ Jamison","year":"2007","unstructured":"The Veterans Affairs Site Investigators, Jamison RJ, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR et al (2007) Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. J Am Med Assoc 298:1163\u20131170","journal-title":"J Am Med Assoc"},{"key":"550_CR24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","volume":"94","author":"K Robinson","year":"1996","unstructured":"Robinson K, Gupta A, Tennis V, Arheart K, Chaudhary D et al (1996) Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743\u20132748","journal-title":"Circulation"},{"key":"550_CR25","first-page":"779","volume":"20","author":"N Azadibakhsh","year":"2009","unstructured":"Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golesan B, Rad AH (2009) Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients. Saudi J Kidney Dis Transpl 20:779\u2013788","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"550_CR26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ndt\/17.5.916","volume":"17","author":"K Koyama","year":"2002","unstructured":"Koyama K, Usami T, Takeuchi O, Morozumi K, Kimura G (2002) Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in hemodialysis patients receiving high dose folic acid supplementation. Nephrol Dil Trans 17:916\u2013922","journal-title":"Nephrol Dil Trans"},{"key":"550_CR27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1523-1755.2001.0590031103.x","volume":"59","author":"B Manns","year":"2001","unstructured":"Manns B, Hyndman E, Burgess E et al (2001) Oral vitamin B12 and high dose folic acid in hemodialysis patients with hyperhomocysteinemia. Kidney Int 59:1103\u20131109","journal-title":"Kidney Int"},{"key":"550_CR28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000057605","volume":"91","author":"H Trimarchi","year":"2002","unstructured":"Trimarchi H, Schiel A, Freixas E, Diaz M (2002) Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron 91:58\u201363","journal-title":"Nephron"},{"key":"550_CR29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa011364","volume":"345","author":"G Schnyder","year":"2001","unstructured":"Schnyder G, Rofil M, Fin R et al (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345:1595\u20131600","journal-title":"N Engl J Med"},{"key":"550_CR30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","volume":"288","author":"G Schnyder","year":"2002","unstructured":"Schnyder G, Rofil M, Flammer Y, Fin R, Hess OM (2002) Effect of homocysteine-lowering therapy with folic acid, vitamin B12 and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288:973\u2013979","journal-title":"JAMA"},{"key":"550_CR31","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","volume":"350","author":"H Lange","year":"2004","unstructured":"Lange H, Saryapranata H, De Luca G et al (2004) Folate therapy and in stent restenosis after coronary stending. N Engl J Med 350:2673\u20132681","journal-title":"N Engl J Med"},{"key":"550_CR32","doi-asserted-by":"crossref","unstructured":"Rimm EB, Willet WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women 279:359\u2013364","DOI":"10.1001\/jama.279.5.359"},{"key":"550_CR33","doi-asserted-by":"crossref","unstructured":"Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) Effect of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA 303:2486\u20132494","DOI":"10.1001\/jama.2010.840"},{"key":"550_CR34","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(99)03383-8","volume":"354","author":"NP Dudman","year":"1999","unstructured":"Dudman NP (1999) An alternative view of homocysteine. Lancet 354:2072\u20132074","journal-title":"Lancet"},{"key":"550_CR35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jacc.2006.04.086","volume":"48l","author":"S Kaul","year":"2006","unstructured":"Kaul S, Zadeh AA, Shah PK (2006) Homocysteine hypothesis for atherothrombotic cardiovascular disease-Not validated. JACC 48l:914\u2013923","journal-title":"JACC"},{"key":"550_CR36","doi-asserted-by":"crossref","first-page":"a3083","DOI":"10.1136\/bmj.a3083","volume":"338","author":"W Ruijter de","year":"2009","unstructured":"de Ruijter W, Westendorp RGJ, Assendelft W, den Elzen WPJ, de Craen JM, le Cessie S, Gyssenkloo J (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 338:a3083","journal-title":"BMJ"},{"key":"550_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","volume":"291","author":"JF Toole","year":"2004","unstructured":"Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. J Am Med Assoc 291:565\u2013575","journal-title":"J Am Med Assoc"},{"key":"550_CR38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","volume":"354","author":"E Lonn","year":"2006","unstructured":"Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J et al (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567\u20131577","journal-title":"N Engl J Med"},{"key":"550_CR39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"KH Bonna","year":"2006","unstructured":"Bonna KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A et al (2006) NORVIT trial investigators homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578\u20131588","journal-title":"N Engl J Med"},{"key":"550_CR40","doi-asserted-by":"crossref","unstructured":"Clarke R, Halsey J, Lewinton S, Lonn E, Armitage J, Manson JAE, Bonaa KH, Spence D, Nygard O, Jamison R, Graziano JM, Guarino P, Bennett D, Mir F, Peto R, Collina R et al. the B-vitamin treatment trialists collaboration (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause specific mortality. Arch Intern Med 170:1622\u20131631","DOI":"10.1001\/archinternmed.2010.348"},{"issue":"3","key":"550_CR41","doi-asserted-by":"crossref","first-page":"e9692","DOI":"10.1371\/journal.pone.0009692","volume":"5","author":"M Kim","year":"2010","unstructured":"Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW (2010) DNA methylation as a biomarker for cardiovascular disease risk. PloS ONE 5(3):e9692. doi: 10.1371\/journal.pone0009692","journal-title":"PloS ONE"},{"key":"550_CR42","doi-asserted-by":"crossref","first-page":"29147","DOI":"10.1074\/jbc.M403618200","volume":"279","author":"G Lund","year":"2004","unstructured":"Lund G, Anderson L, Lauria M, Lindholm M, Fraga MF et al (2004) DNA methylation polymorphism precede histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 279:29147\u201329154","journal-title":"J Biol Chem"},{"key":"550_CR43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinchem\/46.2.265","volume":"46","author":"S Melnyk","year":"2000","unstructured":"Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ (2000) Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5\u2032 phophate concentrations. Clin Chem 46:265\u2013272","journal-title":"Clin Chem"},{"key":"550_CR44","doi-asserted-by":"crossref","first-page":"2361S","DOI":"10.1093\/jn\/132.8.2361S","volume":"132","author":"SJ James","year":"2002","unstructured":"James SJ, Melnik S, Pogribna M, Pogribny IP, Caudill MA (2002) Elevation in S-adenosylhomocysteine and DNA hypo-methylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132:2361S\u20132366S","journal-title":"J Nutr"},{"key":"550_CR45","doi-asserted-by":"crossref","first-page":"29318","DOI":"10.1074\/jbc.M002725200","volume":"275","author":"P Yi","year":"2000","unstructured":"Yi P, Melnik S, Pogribna M, Pogribny IP, Hine RJ, James SJ (2000) Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocite DNA hypo-methylation. J Biol Chem 275:29318\u201329323","journal-title":"J Biol Chem"},{"key":"550_CR46","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1373\/49.8.1292","volume":"48","author":"R Castro","year":"2003","unstructured":"Castro R, Rivera I, Struys EA, Jansen EEW, Ravasco P, Camino ME, Blom HJ, Jakobs C, de Almeida IT (2003) Increased homocysteine and S-adenyl-homocysteine concentrations and DNA hypo-methylation in vascular disease. Clin Chem 48:1292\u20131296","journal-title":"Clin Chem"},{"key":"550_CR47","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1515\/CCLM.2007.350","volume":"45","author":"S Jamaluddin","year":"2007","unstructured":"Jamaluddin S, Yang X, Wang H (2007) Hyper-homocysteinemia, DNA hypomethylation and vascular disease. Clin Chem Lab Med 45:1660\u20131666","journal-title":"Clin Chem Lab Med"},{"key":"550_CR48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1050-1738(99)00002-X","volume":"9","author":"ME Lee","year":"1999","unstructured":"Lee ME, Wang H (1999) Homocysteine and hypomethylation. A novel link to vascular disease. Trends Cardiovasc Med 9:49\u201354","journal-title":"Trends Cardiovasc Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-011-0550-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-011-0550-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-011-0550-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T14:33:56Z","timestamp":1592231636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-011-0550-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s11239-011-0550-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}